96 research outputs found
Biochemical and pharmaceutical traits of Marrubium vulgare L. plants treated with plant growth-promoting bacteria and elevated CO2
No full textThe present research aimed to understand the influence of plant growth-promoting bacteria (PGPB) on various biochemical, nutritional, and pharmaceutical characteristics of Marrubium vulgare plants grown under elevated carbon dioxide (eCO(2)). To achieve this objective, a pot experiment was carried out, consisting of two treatments, namely: (i) biofertilization (Bf) by a PGPB strain (Micromonospora sp.) and (ii) two different air CO2 levels, including ambient CO2 (aCO(2)) and eCO(2) concentrations (410 and 710 mu mol CO2 mol(-1), respectively). The improvement in the photosynthesis rate of eCO(2) and Bf-treated plants can explain the increase in the production of carbohydrate. This is evidenced by a substantial rise, reaching up to + 75% and 25% in the total sugar and starch content in plants subjected to eCO(2) treatment, respectively. Additionally, eCO(2)-treated plants exhibited a remarkable 102% increase in soluble sugar synthesis, while plants subjected to Bf treatment showed a notable increase of 66%. Such modifications could be the main factor affecting plants carbon and nitrogen metabolism. Although the level of certain amino acids (such as glycine, tyrosine, and phenylalanine) in plants exhibited significant increases in response to eCO(2) and Bf, the levels of other amino acids demonstrated enhancements in plants grown under eCO(2) (e.g., histidine) or under treatments containing Bf (e.g., alanine and ornithine). Improvements in primary metabolites led to more benefits in plants treated with Bf and CO2 by boosting secondary metabolites accumulation, including phenolics (+ 27-100%), flavonoids (+ 30-92%), and essential oils (up to + 296%), as well as improved antioxidant capacity (FRAP). This remarkable effectiveness was evident in the significant increase in the biomass production, highlighting the synergistic impact of the treatments. Therefore, the interaction of Bf and eCO(2) not only induced plant biomass accumulation but also improved the nutritional and pharmaceutical value of M. vulgare plants
Gastrointestinal manifestations in children with primary immunodeficiency diseases
No full textNo Abstrac
The Pediatric Allergy and Immunology Unit of Ain Shams University in times of SARS-CoV-2 pandemic: approach and challenges
No full textThe Pediatric Allergy and Immunology (PAI) Unit of Ain Shams University, founded in 1988 by Professor Yehia El-Gamal and currently headed by Professor Shereen Reda, is a tertiary referral center for pediatric allergy, primary immunodeficiency, and rheumatology patients in Egypt. It serves more than 1300 patients with different immunological disorders, with an outpatient and inpatient sections and investigational laboratory. With the widespread of the SARS-CoV-2 and its declaration as a "pandemic", and owing to the heterogeneity of the different disorders managed and followed up in the unit, several measures have been taken in order to provide the necessary services for the patients. This service should maintain a rational balance between the need to mitigate the virus spread and to provide the optimum care for those who get infected, when in the meantime keep their original disease morbidity and mortality to the minimum. These measures were taken by the members of the PAI unit with the help of the head management team of Children’s Hospital, Ain Shams University and were subjected to continuous modification based on the evolving situation, emerging information, problems faced and the availability of human and medical resources
#747 Women and the New East.
No full textParticipants include: Begum Shereen Aziz Ahmed, Wife of the Ambassador of Pakistan to the U.S. Mrs. Hazami Fekini, Wife of the Ambassador of Libya to the U.S. Lillian T. Mowrer, Lecturer and Author of Journalist's Wife and the Indomitable John Scot
Race and Criminal Justice in Canada: An Overview
No full textCanadian Law and Society Association Annual Meeting 2014. University of Manitoba, Faculty of Law, Winnipeg, M
The importance of vaccination and immunoglobulin treatment for patients with primary immunodeficiency diseases (PIDs) ‐ World PI Week April 22–29, 2015
No full textLa importancia de la vacunación y el tratamiento con inmunoglobulina para pacientes con inmunodeficiencias primarias
No full textLas inmunodeficiencias primarias son un grupo heterogéneo de enfermedades genéticas raras
que afectan el desarrollo o el funcionamiento de la inmunidad innata o la adaptativa. La mayoría de los pacientes que las padecen tienen mayor susceptibilidad a infecciones tanto comunes como raras, a veces con desenlace fatal. Por lo tanto es esencial ofrecer tratamiento rápido y eficaz para prevenir infecciones, proporcionando programas de vacunación adecuados
y administrando regularmente el tratamiento con inmunoglobulina G (IgG) de reemplazo, en
los trastornos con defecto en la producción o funcionamiento de los anticuerpos. En algunas
condiciones también está indicada la quimioprofilaxis con antibióticos y antifúngicos
The Expression of Migration Inhibitory Factor mRNA in Peripheral Blood of Children with Systemic Lupus Erythematosus
No full text- …
